Eloxx Pharmaceut Stock Price, News & Analysis
Company Description
Eloxx Pharmaceut (OTC Link: ELOX) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $314.0.
ELOX stock has gained 0.0% over the past year. Shares last traded at $0.1300.
This page provides a comprehensive overview of ELOX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Eloxx Pharmaceut (ELOX) stock last traded at $0.1300. At a market capitalization of $314.0, ELOX is classified as a micro-cap stock with approximately 5.1M shares outstanding.
Latest News
Eloxx Pharmaceut has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, management, clinical trial, offering. View all ELOX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Eloxx Pharmaceut (ELOX) currently stands at 2.1 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 29.3 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Eloxx Pharmaceut (ELOX) currently stands at 29.3 days, up 2831% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 1687.2% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
ELOX Company Profile & Sector Positioning
Eloxx Pharmaceut (ELOX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ELOX often look at related companies in the same sector, including Regenerx Biopharmaceuticals (RGRX), Neximmune, Inc. (NEXI), Effector Therapeutics Inc (EFTR), Gritstone Bio Inc (GRTSQ), and Innoveren Scientific Inc (IVRN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ELOX's relative position within its industry.